Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
1(50.0%)
Phase 4
1(50.0%)
2Total
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06624631Phase 4Recruiting

PDMC Implementation Trial in Kenya

Role: collaborator

NCT05319717Phase 2Completed

Rice Bran-based Supplemental Foods for the Treatment of Childhood Malnutrition

Role: collaborator

NCT05199831Completed

Situational Analysis of HIV-related Disability in the Context of Ivory Coast

Role: collaborator

NCT03215732Completed

Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, Senegal

Role: collaborator

All 4 trials loaded